Product NDC: | 76329-8261 |
Proprietary Name: | Lorazepam |
Non Proprietary Name: | Lorazepam |
Active Ingredient(s): | 2 mg/mL & nbsp; Lorazepam |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 76329-8261 |
Labeler Name: | International Medication Systems, Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076150 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121201 |
Package NDC: | 76329-8261-1 |
Package Description: | 10 VIAL in 1 CARTON (76329-8261-1) > 10 mL in 1 VIAL |
NDC Code | 76329-8261-1 |
Proprietary Name | Lorazepam |
Package Description | 10 VIAL in 1 CARTON (76329-8261-1) > 10 mL in 1 VIAL |
Product NDC | 76329-8261 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lorazepam |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20121201 |
Marketing Category Name | ANDA |
Labeler Name | International Medication Systems, Limited |
Substance Name | LORAZEPAM |
Strength Number | 2 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |